Navigating Europe’s complex environmental and sustainability legislation can be daunting, but healthcare product ...
A top US Food and Drug Administration (FDA) enforcement official announced that the agency conducted more unannounced drug ...
More than 500 comments have been submitted in response to the US Food and Drug Administration’s (FDA) discussion paper on ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, ...
Sponsored Content] Health Canada’s 14 September 2026 interim policy introduces flexibility in ethics reporting, investigator ...
The Hong Kong Department of Health has unveiled the timetable for launching its Centre for Medical Products Regulation (CMPR) and starting to approve medical products directly. In 2023, government ...
Patients who reviewed and signed a patient agreement form (PAF) for mifepristone and misoprostol under the US Food and Drug ...
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
The US Food and Drug Administration (FDA) on Tuesday issued draft guidance on submitting investigational device exemption ...
The US Food and Drug Administration (FDA) issued revised draft guidance on Thursday aimed at assisting sponsors of ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, ...
An expert and officials from the US Food and Drug Administration (FDA) offered tips for de novo classification requests and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results